COVID-19 Impact on Neglected Tropical Diseases Diagnosis Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Neglected Tropical Diseases Diagnosis, including the following market information:
Major competitors identified in this market include Abbott Laboratories, Beckman Coulter/Danaher, Bio-Rad Laboratories, Inc., Life Technology, Novartis Diagnostics., Ltd., Ortho-Clinical Diagnostics, Premier Medical Corporation Ltd., Siemens Healthcare, Wako Chemicals, Inc., etc.
Based on the Region:
- Global Neglected Tropical Diseases Diagnosis Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Neglected Tropical Diseases Diagnosis Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Neglected Tropical Diseases Diagnosis Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Neglected Tropical Diseases Diagnosis Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Abbott Laboratories, Beckman Coulter/Danaher, Bio-Rad Laboratories, Inc., Life Technology, Novartis Diagnostics., Ltd., Ortho-Clinical Diagnostics, Premier Medical Corporation Ltd., Siemens Healthcare, Wako Chemicals, Inc., etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Conventional Method
- Molecular/Modern Method
- Clinical Labs
- Hospitals /Clinics
- Home Healthcare
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Neglected Tropical Diseases Diagnosis Industry
1.7 COVID-19 Impact: Neglected Tropical Diseases Diagnosis Market Trends
2 GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS QUARTERLY MARKET SIZE ANALYSIS
2.1 Neglected Tropical Diseases Diagnosis Business Impact Assessment - COVID-19
2.1.1 Global Neglected Tropical Diseases Diagnosis Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Neglected Tropical Diseases Diagnosis Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Neglected Tropical Diseases Diagnosis Quarterly Market Size, 2019 VS 2020
3.2 By Players, Neglected Tropical Diseases Diagnosis Headquarters and Area Served
3.3 Date of Key Players Enter into Neglected Tropical Diseases Diagnosis Market
3.4 Key Players Neglected Tropical Diseases Diagnosis Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON NEGLECTED TROPICAL DISEASES DIAGNOSIS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Conventional Method
1.4.2 Molecular/Modern Method
4.2 By Type, Global Neglected Tropical Diseases Diagnosis Market Size, 2019-2021
5 IMPACT OF COVID-19 ON NEGLECTED TROPICAL DISEASES DIAGNOSIS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Clinical Labs
5.5.2 Hospitals /Clinics
5.5.3 Home Healthcare
5.2 By Application, Global Neglected Tropical Diseases Diagnosis Market Size, 2019-2021
5.2.1 By Application, Global Neglected Tropical Diseases Diagnosis Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Business Overview
7.1.2 Abbott Laboratories Neglected Tropical Diseases Diagnosis Quarterly Revenue, 2020
7.1.3 Abbott Laboratories Neglected Tropical Diseases Diagnosis Product Introduction
7.1.4 Abbott Laboratories Response to COVID-19 and Related Developments
7.2 Beckman Coulter/Danaher
7.2.1 Beckman Coulter/Danaher Business Overview
7.2.2 Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Quarterly Revenue, 2020
7.2.3 Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Product Introduction
7.2.4 Beckman Coulter/Danaher Response to COVID-19 and Related Developments
7.3 Bio-Rad Laboratories, Inc.
7.3.1 Bio-Rad Laboratories, Inc. Business Overview
7.3.2 Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Quarterly Revenue, 2020
7.3.3 Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Product Introduction
7.3.4 Bio-Rad Laboratories, Inc. Response to COVID-19 and Related Developments
7.4 Life Technology
7.4.1 Life Technology Business Overview
7.4.2 Life Technology Neglected Tropical Diseases Diagnosis Quarterly Revenue, 2020
7.4.3 Life Technology Neglected Tropical Diseases Diagnosis Product Introduction
7.4.4 Life Technology Response to COVID-19 and Related Developments
7.5 Novartis Diagnostics., Ltd.
7.5.1 Novartis Diagnostics., Ltd. Business Overview
7.5.2 Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Quarterly Revenue, 2020
7.5.3 Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Product Introduction
7.5.4 Novartis Diagnostics., Ltd. Response to COVID-19 and Related Developments
7.6 Ortho-Clinical Diagnostics
7.6.1 Ortho-Clinical Diagnostics Business Overview
7.6.2 Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Quarterly Revenue, 2020
7.6.3 Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Product Introduction
7.6.4 Ortho-Clinical Diagnostics Response to COVID-19 and Related Developments
7.7 Premier Medical Corporation Ltd.
7.7.1 Premier Medical Corporation Ltd. Business Overview
7.7.2 Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Quarterly Revenue, 2020
7.7.3 Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Product Introduction
7.7.4 Premier Medical Corporation Ltd. Response to COVID-19 and Related Developments
7.8 Siemens Healthcare
7.8.1 Siemens Healthcare Business Overview
7.8.2 Siemens Healthcare Neglected Tropical Diseases Diagnosis Quarterly Revenue, 2020
7.8.3 Siemens Healthcare Neglected Tropical Diseases Diagnosis Product Introduction
7.8.4 Siemens Healthcare Response to COVID-19 and Related Developments
7.9 Wako Chemicals, Inc.
7.9.1 Wako Chemicals, Inc. Business Overview
7.9.2 Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Quarterly Revenue, 2020
7.9.3 Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Product Introduction
7.9.4 Wako Chemicals, Inc. Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Neglected Tropical Diseases Diagnosis Industry
1.7 COVID-19 Impact: Neglected Tropical Diseases Diagnosis Market Trends
2 GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS QUARTERLY MARKET SIZE ANALYSIS
2.1 Neglected Tropical Diseases Diagnosis Business Impact Assessment - COVID-19
2.1.1 Global Neglected Tropical Diseases Diagnosis Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Neglected Tropical Diseases Diagnosis Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Neglected Tropical Diseases Diagnosis Quarterly Market Size, 2019 VS 2020
3.2 By Players, Neglected Tropical Diseases Diagnosis Headquarters and Area Served
3.3 Date of Key Players Enter into Neglected Tropical Diseases Diagnosis Market
3.4 Key Players Neglected Tropical Diseases Diagnosis Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON NEGLECTED TROPICAL DISEASES DIAGNOSIS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Conventional Method
1.4.2 Molecular/Modern Method
4.2 By Type, Global Neglected Tropical Diseases Diagnosis Market Size, 2019-2021
5 IMPACT OF COVID-19 ON NEGLECTED TROPICAL DISEASES DIAGNOSIS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Clinical Labs
5.5.2 Hospitals /Clinics
5.5.3 Home Healthcare
5.2 By Application, Global Neglected Tropical Diseases Diagnosis Market Size, 2019-2021
5.2.1 By Application, Global Neglected Tropical Diseases Diagnosis Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Business Overview
7.1.2 Abbott Laboratories Neglected Tropical Diseases Diagnosis Quarterly Revenue, 2020
7.1.3 Abbott Laboratories Neglected Tropical Diseases Diagnosis Product Introduction
7.1.4 Abbott Laboratories Response to COVID-19 and Related Developments
7.2 Beckman Coulter/Danaher
7.2.1 Beckman Coulter/Danaher Business Overview
7.2.2 Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Quarterly Revenue, 2020
7.2.3 Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Product Introduction
7.2.4 Beckman Coulter/Danaher Response to COVID-19 and Related Developments
7.3 Bio-Rad Laboratories, Inc.
7.3.1 Bio-Rad Laboratories, Inc. Business Overview
7.3.2 Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Quarterly Revenue, 2020
7.3.3 Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Product Introduction
7.3.4 Bio-Rad Laboratories, Inc. Response to COVID-19 and Related Developments
7.4 Life Technology
7.4.1 Life Technology Business Overview
7.4.2 Life Technology Neglected Tropical Diseases Diagnosis Quarterly Revenue, 2020
7.4.3 Life Technology Neglected Tropical Diseases Diagnosis Product Introduction
7.4.4 Life Technology Response to COVID-19 and Related Developments
7.5 Novartis Diagnostics., Ltd.
7.5.1 Novartis Diagnostics., Ltd. Business Overview
7.5.2 Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Quarterly Revenue, 2020
7.5.3 Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Product Introduction
7.5.4 Novartis Diagnostics., Ltd. Response to COVID-19 and Related Developments
7.6 Ortho-Clinical Diagnostics
7.6.1 Ortho-Clinical Diagnostics Business Overview
7.6.2 Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Quarterly Revenue, 2020
7.6.3 Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Product Introduction
7.6.4 Ortho-Clinical Diagnostics Response to COVID-19 and Related Developments
7.7 Premier Medical Corporation Ltd.
7.7.1 Premier Medical Corporation Ltd. Business Overview
7.7.2 Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Quarterly Revenue, 2020
7.7.3 Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Product Introduction
7.7.4 Premier Medical Corporation Ltd. Response to COVID-19 and Related Developments
7.8 Siemens Healthcare
7.8.1 Siemens Healthcare Business Overview
7.8.2 Siemens Healthcare Neglected Tropical Diseases Diagnosis Quarterly Revenue, 2020
7.8.3 Siemens Healthcare Neglected Tropical Diseases Diagnosis Product Introduction
7.8.4 Siemens Healthcare Response to COVID-19 and Related Developments
7.9 Wako Chemicals, Inc.
7.9.1 Wako Chemicals, Inc. Business Overview
7.9.2 Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Quarterly Revenue, 2020
7.9.3 Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Product Introduction
7.9.4 Wako Chemicals, Inc. Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Neglected Tropical Diseases Diagnosis Assessment
Table 9. COVID-19 Impact: Neglected Tropical Diseases Diagnosis Market Trends
Table 10. COVID-19 Impact Global Neglected Tropical Diseases Diagnosis Market Size
Table 11. Global Neglected Tropical Diseases Diagnosis Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Neglected Tropical Diseases Diagnosis Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Neglected Tropical Diseases Diagnosis Market Growth Drivers
Table 14. Global Neglected Tropical Diseases Diagnosis Market Restraints
Table 15. Global Neglected Tropical Diseases Diagnosis Market Opportunities
Table 16. Global Neglected Tropical Diseases Diagnosis Market Challenges
Table 17. By Players, Neglected Tropical Diseases Diagnosis Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Neglected Tropical Diseases Diagnosis Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Neglected Tropical Diseases Diagnosis Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Neglected Tropical Diseases Diagnosis Market
Table 21. Key Players Neglected Tropical Diseases Diagnosis Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Neglected Tropical Diseases Diagnosis Market Size 2019-2021, (US$ Million)
Table 24. Global Neglected Tropical Diseases Diagnosis Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Neglected Tropical Diseases Diagnosis Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 57. Abbott Laboratories Business Overview
Table 58. Abbott Laboratories Neglected Tropical Diseases Diagnosis Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Abbott Laboratories Neglected Tropical Diseases Diagnosis Product
Table 60. Abbott Laboratories Response to COVID-19 and Related Developments
Table 61. Beckman Coulter/Danaher Business Overview
Table 62. Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Product
Table 64. Beckman Coulter/Danaher Response to COVID-19 and Related Developments
Table 65. Bio-Rad Laboratories, Inc. Business Overview
Table 66. Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Product
Table 68. Bio-Rad Laboratories, Inc. Response to COVID-19 and Related Developments
Table 69. Life Technology Business Overview
Table 70. Life Technology Neglected Tropical Diseases Diagnosis Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Life Technology Neglected Tropical Diseases Diagnosis Product
Table 72. Life Technology Response to COVID-19 and Related Developments
Table 73. Novartis Diagnostics., Ltd. Business Overview
Table 74. Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Product
Table 76. Novartis Diagnostics., Ltd. Response to COVID-19 and Related Developments
Table 77. Ortho-Clinical Diagnostics Business Overview
Table 78. Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Product
Table 80. Ortho-Clinical Diagnostics Response to COVID-19 and Related Developments
Table 81. Premier Medical Corporation Ltd. Business Overview
Table 82. Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Product
Table 84. Premier Medical Corporation Ltd. Response to COVID-19 and Related Developments
Table 85. Siemens Healthcare Business Overview
Table 86. Siemens Healthcare Neglected Tropical Diseases Diagnosis Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Siemens Healthcare Neglected Tropical Diseases Diagnosis Product
Table 88. Siemens Healthcare Response to COVID-19 and Related Developments
Table 89. Wako Chemicals, Inc. Business Overview
Table 90. Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Product
Table 92. Wako Chemicals, Inc. Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Neglected Tropical Diseases Diagnosis Assessment
Table 9. COVID-19 Impact: Neglected Tropical Diseases Diagnosis Market Trends
Table 10. COVID-19 Impact Global Neglected Tropical Diseases Diagnosis Market Size
Table 11. Global Neglected Tropical Diseases Diagnosis Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Neglected Tropical Diseases Diagnosis Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Neglected Tropical Diseases Diagnosis Market Growth Drivers
Table 14. Global Neglected Tropical Diseases Diagnosis Market Restraints
Table 15. Global Neglected Tropical Diseases Diagnosis Market Opportunities
Table 16. Global Neglected Tropical Diseases Diagnosis Market Challenges
Table 17. By Players, Neglected Tropical Diseases Diagnosis Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Neglected Tropical Diseases Diagnosis Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Neglected Tropical Diseases Diagnosis Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Neglected Tropical Diseases Diagnosis Market
Table 21. Key Players Neglected Tropical Diseases Diagnosis Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Neglected Tropical Diseases Diagnosis Market Size 2019-2021, (US$ Million)
Table 24. Global Neglected Tropical Diseases Diagnosis Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Neglected Tropical Diseases Diagnosis Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Neglected Tropical Diseases Diagnosis Market Size, 2019-2021 (US$ Million)
Table 57. Abbott Laboratories Business Overview
Table 58. Abbott Laboratories Neglected Tropical Diseases Diagnosis Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Abbott Laboratories Neglected Tropical Diseases Diagnosis Product
Table 60. Abbott Laboratories Response to COVID-19 and Related Developments
Table 61. Beckman Coulter/Danaher Business Overview
Table 62. Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Product
Table 64. Beckman Coulter/Danaher Response to COVID-19 and Related Developments
Table 65. Bio-Rad Laboratories, Inc. Business Overview
Table 66. Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Product
Table 68. Bio-Rad Laboratories, Inc. Response to COVID-19 and Related Developments
Table 69. Life Technology Business Overview
Table 70. Life Technology Neglected Tropical Diseases Diagnosis Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Life Technology Neglected Tropical Diseases Diagnosis Product
Table 72. Life Technology Response to COVID-19 and Related Developments
Table 73. Novartis Diagnostics., Ltd. Business Overview
Table 74. Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Product
Table 76. Novartis Diagnostics., Ltd. Response to COVID-19 and Related Developments
Table 77. Ortho-Clinical Diagnostics Business Overview
Table 78. Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Product
Table 80. Ortho-Clinical Diagnostics Response to COVID-19 and Related Developments
Table 81. Premier Medical Corporation Ltd. Business Overview
Table 82. Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Product
Table 84. Premier Medical Corporation Ltd. Response to COVID-19 and Related Developments
Table 85. Siemens Healthcare Business Overview
Table 86. Siemens Healthcare Neglected Tropical Diseases Diagnosis Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Siemens Healthcare Neglected Tropical Diseases Diagnosis Product
Table 88. Siemens Healthcare Response to COVID-19 and Related Developments
Table 89. Wako Chemicals, Inc. Business Overview
Table 90. Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Product
Table 92. Wako Chemicals, Inc. Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Neglected Tropical Diseases Diagnosis Product Picture
Figure 2. Neglected Tropical Diseases Diagnosis Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Neglected Tropical Diseases Diagnosis Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Neglected Tropical Diseases Diagnosis Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Neglected Tropical Diseases Diagnosis Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Neglected Tropical Diseases Diagnosis Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Neglected Tropical Diseases Diagnosis Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Neglected Tropical Diseases Diagnosis Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Neglected Tropical Diseases Diagnosis Market Size Market Share, 2019-2021
Figure 1. Neglected Tropical Diseases Diagnosis Product Picture
Figure 2. Neglected Tropical Diseases Diagnosis Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Neglected Tropical Diseases Diagnosis Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Neglected Tropical Diseases Diagnosis Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Neglected Tropical Diseases Diagnosis Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Neglected Tropical Diseases Diagnosis Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Neglected Tropical Diseases Diagnosis Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Neglected Tropical Diseases Diagnosis Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Neglected Tropical Diseases Diagnosis Market Size Market Share, 2019-2021
